EGFR and neoplasm: In this cancer type, IFIT1 overexpression promotes tumor growth and metastasis through epithelial-mesenchymal transition (EMT), while its silencing leads to opposite effects, likely through enhanced p-EGFR (phosphorylated epidermal growth factor receptor) recycling [16].